Pricing Log in Create free account

GH Research PLC (GHRS) vs Silence Therapeutics PLC Sponsored ADR (SLN)

GH Research PLC and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. GH Research PLC and Silence Therapeutics PLC Sponsored ADR are of similar size ($1.3B and $1.2B). Across the 9 metrics below, GH Research PLC leads on 7 and Silence Therapeutics PLC Sponsored ADR on 2.

Valuation

Metric GHRS SLN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1,110.83 9.40
P/B 3.42 24.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1,025.03 9.02
Earnings yield (5.41%) (6.49%) (32.88%)
Free cash flow yield (4.21%) (4.54%) (23.13%)

Profitability

Metric GHRS SLN Biotechnology median
Gross margin 0.00% 79.50% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (18.79%) (90.41%) (51.96%)
Return on assets (18.16%) (44.14%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GHRS SLN Biotechnology median
Revenue growth (TTM) — (96.97%) 6.76%
EPS growth (last fiscal year) (5.33%) (90.91%) 29.88%
Revenue growth, 5-year CAGR — (39.74%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GHRS SLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 28.70 7.42 4.97
Net debt to EBITDA 4.65 0.94 1.01

Dividend

Metric GHRS SLN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GHRS SLN Biotechnology median
Market cap 1.27b 1.23b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack